Compare IH & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | DTIL |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 128.8M |
| IPO Year | 2020 | 2019 |
| Metric | IH | DTIL |
|---|---|---|
| Price | $1.70 | $6.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 6.7K | ★ 317.3K |
| Earning Date | 03-27-2026 | 03-12-2026 |
| Dividend Yield | ★ 4.76% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | $34.75 |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $3.53 |
| 52 Week High | $3.60 | $8.82 |
| Indicator | IH | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 59.75 |
| Support Level | $1.74 | $3.96 |
| Resistance Level | $3.06 | $7.59 |
| Average True Range (ATR) | 0.15 | 0.58 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 16.22 | 44.61 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.